|
Class 2 Device Recall Pipeline Embolization Device |
|
Date Initiated by Firm |
July 19, 2013 |
Date Posted |
August 23, 2013 |
Recall Status1 |
Terminated 3 on October 17, 2013 |
Recall Number |
Z-2045-2013 |
Recall Event ID |
65810 |
PMA Number |
P100018 |
Product Classification |
Intracranial aneurysm flow diverter - Product Code OUT
|
Product |
Pipeline Embolization Device (PED)
The Pipeline Embolization Device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide-necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments. |
Code Information |
Model/Lot Numbers: FA-71400-25 / 9747602 FA-77350-18 / 9749412 FA-77400-20 / 9759088 FA-71500-35 / 9747604 FA-77375-16 / 9744487 FA-77425-16 / 9752788 FA-77300-16 / 9757068 FA-77375-20 / 9757065 FA-77425-20 / 9744123 FA-77325-14 / 9759141 FA-77400-14 / 9757233 FA-77425-20 / 9752438 FA-77325-16 / 9753034 FA-77400-14 / 9768698 FA-77450-18 / 9753033 FA-77325-16 / 9757024 FA-77400-16 / 9743468 FA-77475-20 / 9752787 FA-77325-18 / 9759560 FA-77400-18 / 9751579 FA-77500-20 / 9750678 FA-77350-16 / 9752785 FA-77400-20 / 9755707 |
Recalling Firm/ Manufacturer |
Micro Therapeutics Inc, Dba Ev3 Neurovascular 9775 Toledo Way Irvine CA 92618-1811
|
For Additional Information Contact |
949-839-3700
|
Manufacturer Reason for Recall |
Covidien Neurovascular has initiated the recall of several lots of Pipeline Embolization Device (PED) because the Instructions For Use (IFU) do not include the following contraindication: Patients in whom a pre-existing stent is in place in the parent artery at the target aneurysm location. Additionally, the designation of aspirin and clopidogrel was missing from the following contraindication "
|
FDA Determined Cause 2 |
Employee error |
Action |
Covidien sent an Customer Notification letter dated July 19, 2013, to all affected customers who received affected lots of Pipeline Embolization Device (PED).
The customer notification letter informed the customers of the problems identified and the actions to be taken. Customer are instructed to reply and fax response form to Covidien Customer Service at (763) 398-7001. Customers are instructed that Customer Service will issue an RGA number for the return of the affected product back to Covidien. Customers are also instructed that upon receipt of a Returned Goods Authorization (RGA) number, to write the
RGA number on the FEDEX slip and send the product back to:
Covidien
Attention: Product Recall
14005 13th Ave
Plymouth, MN 55441
Prepaid and preaddressed FEDEX slips are enclosed for their convenience.
Once Covidien receives the returned units, product replacement units will be shipped directly to customers. Local Covidien Neurovascular representative is also available to assist them in expediting the exchange of product.
Customers with any questions, are instructed to call (949) 839-3700. |
Quantity in Commerce |
62 units |
Distribution |
US Distribution including the states of AZ, KY, MO, NC, GA, WI, OR, FL, NY, CA, IL, TN, NV, TX, CO, MA, IA, UT and VA. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
PMA Database |
PMAs with Product Code = OUT and Original Applicant = Micro Therapeutics, Inc. d/b/a ev3 NEUROVASCULAR
|
|
|
|